These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6083808)

  • 41. Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid after total and REM sleep deprivation in humans.
    Livrea P; Di Reda L; Puca FM; Genco S; Specchio LM; Papagno G
    Eur Neurol; 1977; 16(1-6):280-5. PubMed ID: 210022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid levels of cyclic nucleotides and monoaminergic metabolites in subarachnoid haemorrhage: preliminary report.
    Gerosa MA; Olivi A; Longatti PL; Teolato A; Carteri A
    Neurochirurgia (Stuttg); 1981 Mar; 24(2):64-6. PubMed ID: 6163998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid.
    Johansson B; Roos BE
    Acta Neurol Scand; 1975 Aug; 52(2):137-44. PubMed ID: 1155031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acidic metabolites of dopamine and serotonin in cerebrospinal fluid.
    Sourkes TL
    Adv Neurol; 1974; 5():271-3. PubMed ID: 4440576
    [No Abstract]   [Full Text] [Related]  

  • 45. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
    Inagawa T
    Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of diazepam on sleep, temperature, 5-hydroxyindoleacetic and homovanillic acids in cisternal cerebrospinal fluid of cats.
    Griauzde ML; Chen EH; Radulovacki M
    Pharmacology; 1979; 19(3):149-55. PubMed ID: 523505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
    Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular cerebrospinal fluid of patients with obstructive hydrocephalus.
    Kmieciak-Kolada K; Majchrzak H; Herman ZS
    J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):78-81. PubMed ID: 216782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid monoamine metabolites in patients with infantile spasms.
    Silverstein F; Johnston MV
    Neurology; 1984 Jan; 34(1):102-5. PubMed ID: 6197678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary results.
    Maira G; Bareggi SR; Di Rocco C; Calderini G; Morselli PL
    J Neurol Neurosurg Psychiatry; 1975 Feb; 38(2):123-8. PubMed ID: 1151392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trauma induced alterations of concentration of monoamine metabolites in human cerebrospinal fluid.
    Jéquier E; Foroglou G; Zander E
    Surg Neurol; 1974 Jul; 2(4):247-50. PubMed ID: 4835358
    [No Abstract]   [Full Text] [Related]  

  • 52. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
    Muizelaar JP; Oberink JI
    Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visual averaged evoked responses in psychiatric patients. Relationship to levels of 5-hydroxy-indoleacetic acid, homovanilic acid and tryptophan in cerebrospinal fluid.
    Perris C; Gottfries CG; von Knorring L
    J Psychiatr Res; 1979; 15(3):175-81. PubMed ID: 94355
    [No Abstract]   [Full Text] [Related]  

  • 54. Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
    Arch Gen Psychiatry; 1977 May; 34(5):545-50. PubMed ID: 860891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid amine metabolic end-products: biochemical correlates of intelligence.
    Sishta SK; Templer DI
    Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):601-4. PubMed ID: 128085
    [No Abstract]   [Full Text] [Related]  

  • 56. Hemiballismus: changes in cerebrospinal fluid.
    Kostic V; Djuricic B; Paschen W
    Acta Neurol Scand; 1988 Aug; 78(2):115-7. PubMed ID: 2459894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid.
    Garelis E; Sourkes TL
    J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):625-9. PubMed ID: 4731331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests.
    Banki CM; Arató M; Papp Z; Kurcz M
    J Affect Disord; 1984 Jun; 6(3-4):341-50. PubMed ID: 6205031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amine metabolites and neuroendocrine responses related to depression and suicide.
    Banki CM; Arató M
    J Affect Disord; 1983 Aug; 5(3):223-32. PubMed ID: 6193156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients.
    Wode-Helgodt B; Fyrö B; Gullberg B; Sedvall G
    Acta Psychiatr Scand; 1977 Aug; 56(2):129-42. PubMed ID: 899844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.